P621-1336 Screening compound: 4-butyl-2-(4-ethylpiperazine-1-carbonyl)-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one

P621-1336 Screening compound: 4-butyl-2-(4-ethylpiperazine-1-carbonyl)-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one
P621-1336 Screening compound: 4-butyl-2-(4-ethylpiperazine-1-carbonyl)-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P621-1336
4-butyl-2-(4-ethylpiperazine-1-carbonyl)-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P621-1336

Molecular Formula

C19H28N4O3 (C19 H28 N4 O3)

Compound Name

4-butyl-2-(4-ethylpiperazine-1-carbonyl)-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one

IUPAC name

4-butyl-2-(4-ethylpiperazine-1-carbonyl)-2-methyl-2H3H4H-pyrido[32-b][14]oxazin-3-one

SMILES

CCCCN1c2ncccc2OC(C)(C(N2CCN(CC)CC2)=O)C1=O

InChI

InChI=1S/C19H28N4O3/c1-4-6-10-23-16-15(8-7-9-20-16)26-19(3,18(23)25)17(24)22-13-11-21(5-2)12-14-22/h7-9H,4-6,10-14H2,1-3H3/t19-/m0/s1

InChI Key

ODOPGKLLTCPDOQ-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27607158

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

360.46

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.013

Distribution Coefficient, logD

1.528

Water Solubility, LogSw

-2.04

Polar Surface Area

53.087

Acid Dissociation Constant (pKa)

25.99

Base Dissociation Constant (pKb)

7.71

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

63.20

P621-1336 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Soluble Diversity Library (15920 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Nervous system
  • Eye
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Ion Channels
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P621-1336 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P621-1336?
Check Price and Availability of P621-1336, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P621-1336 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P621-1336
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P621-1336
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P621-1336 available by request